Nuzenio

Cntx

Cntx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 09:16:53 GMTContext Therapeutics Inc (CNTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Thu, 06 Aug 2026 23:20:13 GMTContext Therapeutics Inc. Stock 12‑Month Price Target Cut to $4.56, Implies 557% Upside - TradingView
Thu, 06 Aug 2026 07:14:59 GMTKey facts: NASDAQ:CNTX to dose CT-202 in Q3'26; shares -30%; $5 target - TradingView
Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - TradingView
Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - Stock Titan
Thu, 06 Aug 2026 01:20:01 GMTContext Therapeutics (NASDAQ:CNTX) Announces Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cntx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.